Search - tctmd.com

Displaying 341 - 358 of 358

Sort: Relevancy | Date

News Industry News

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

April 03, 2011

News Industry News

2011 ACCF/AHA Guidelines Incorporate New Recommendation for Platelet Reactivity Testing

March 31, 2011

News Industry News

Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction

March 29, 2011

News Industry News

Boston Scientific Announces its ACC 2011 Schedule

March 29, 2011

News Industry News

Abbott to Present Data on Novel Vascular Technologies and XIENCE V® at ACC 2011

March 28, 2011

News Daily News

Calcium Scanning May Lower CAD Risk at No Extra Cost

March 23, 2011

News Industry News

STENTYS expands operations into four additional European countries

March 17, 2011

News Daily News

Women Less Likely to Receive Evidence-Based Therapies Than Men

Jason Kahn

March 09, 2011

News Industry News

2011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery

March 08, 2011

News Industry News

Miracor reports successful completion of the ‘Prepare PICSO’ clinical trial

March 03, 2011

News Industry News

Stereotaxis Announces First Worldwide Use of Remote Magnetic Navigation for Renal Ablation to Treat Hypertension

February 22, 2011

News Industry News

Increased reimbursement of STENTYS drug-eluting stent in Germany

February 22, 2011

News Daily News

CREST Analysis Breaks Down Results in Symptomatic, Asymptomatic Patients

L.A. McKeown

February 17, 2011

News Industry News

Merck Says Additional Information Provided to Investigators in Clinical Study of Vorapaxar

January 18, 2011

News Industry News

EKOS Corporation Receives CE Mark to Treat Massive and Sub-Massive Pulmonary Embolism

January 16, 2011

News Industry News

Merck Statement on Changes to Clinical Studies of Vorapaxar

January 12, 2011

News Industry News

Juventas Therapeutics Initiating Phase II Clinical Trial of JVS-100 for Treatment of Critical Limb Ischemia

January 02, 2011

News Daily News

JUPITER: Rosuvastatin Cuts Heart Risk, Even In LDL-Normal Patients

November 11, 2008

Advertisement

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

2011 ACCF/AHA Guidelines Incorporate New Recommendation for Platelet Reactivity Testing

Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction

Boston Scientific Announces its ACC 2011 Schedule

Abbott to Present Data on Novel Vascular Technologies and XIENCE V® at ACC 2011

Calcium Scanning May Lower CAD Risk at No Extra Cost

STENTYS expands operations into four additional European countries

Women Less Likely to Receive Evidence-Based Therapies Than Men

2011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery

Miracor reports successful completion of the ‘Prepare PICSO’ clinical trial

Stereotaxis Announces First Worldwide Use of Remote Magnetic Navigation for Renal Ablation to Treat Hypertension

Increased reimbursement of STENTYS drug-eluting stent in Germany

CREST Analysis Breaks Down Results in Symptomatic, Asymptomatic Patients

Merck Says Additional Information Provided to Investigators in Clinical Study of Vorapaxar

EKOS Corporation Receives CE Mark to Treat Massive and Sub-Massive Pulmonary Embolism

Merck Statement on Changes to Clinical Studies of Vorapaxar

Juventas Therapeutics Initiating Phase II Clinical Trial of JVS-100 for Treatment of Critical Limb Ischemia

JUPITER: Rosuvastatin Cuts Heart Risk, Even In LDL-Normal Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content